LARGO, Fla., June 13, 2023 (Newswire.com) – PharmaLink, Inc., an Industry-leading pharmaceutical reverse distributor, announced today a new contract relationship with biopharmaceutical manufacturer Merck Sharp & Dohme LLC (Merck). The new Returns Processing Service Agreement is expected to enhance the returns process for downstream customers while maintaining the integrity of supply chain security.
In tandem with this new contract, Merck will issue an updated Product Return Policy complete with directions to acquire a returned goods authorization on PharmaLink’s web portal and new policy parameters. Returns processing activities will be assumed by PharmaLink beginning June 20, 2023. Read more >
